Hemorrhgic and thromboembolic complications during warfarin anticoagulation therapy / 中国实用内科杂志
Chinese Journal of Practical Internal Medicine
; (12)2001.
Article
in Zh
| WPRIM
| ID: wpr-557869
Responsible library:
WPRO
ABSTRACT
Objective To study the incidence of and identity risk factors for hemorrhage and thromboembolism during long-term warfarin therapy.Methods All patients were studied in the People's Hospital of Peking University Anticoagulant Clinic from 2001-04 to 2003-11,in whom a course of warfarin therapy intended to last for more than 4 weeks.All bleeding and thromboembolism events were classified as minor or serious or fatal and life-threatening.Incidences of adverse events were analyzed statistically.Results A total of 128 patients were enrolled in the investigation,the median age of the study group was 67 years(ranged 25 to 83).There were 41 bleeding events occurring in 34 patients,and 5 events of thromboembolism.Age and hepatocirrhosis were significantly associated with bleeding complications(P=0.040 and P=0.014).Conclusion Hemorrhage is the major side effect of warfarin;age and hepatocirrhosis are significantly associated with bleeding complications.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Practical Internal Medicine
Year:
2001
Type:
Article